Tiago Reis Marques
Board Member
Pasithea Therapeutics Corp. (KTTA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tiago Reis Marques
Tiago Reis Marques is recorded as Board Member at Pasithea Therapeutics Corp. (KTTA). Pasithea Therapeutics Corp. reported in an 8-K filed December 19, 2023 that Tiago Reis Marques was appointed director, effective December 19, 2023. The proxy statement of Pasithea Therapeutics Corp. reports total compensation of $1,327,518 for Tiago Reis Marques in fiscal 2025, including a base salary of $533,610. Disclosed compensation is on record for 6 fiscal years.
“Dr. Tiago Reis Marques, each to serve a one-year term expiring at the 2024 annual meeting of stockholders”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pasithea Therapeutics Corp.
Other people whose current roles at this company are on record from its filings.
- Dr. Tiago Reis Marques CEO, Board Member
- Prof. Lawrence Steinman Chairman
- Daniel Schneiderman CFO
- Dr. Yassine Bendiabdallah COO
- Alfred J. Novak Board Member
- Alfred Novak Board Member
- Dr. Emer Leahy Board Member
- Emer Leahy Board Member
- Lawrence Steinman Board Member
- Simon Dumesnil Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $533,610 | $1,327,518 |
| 2024 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $450,000 | $640,059 |
| 2023 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $450,000 | $537,347 |
| 2022 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $450,000 | $539,250 |
| 2021 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | $243,750 | $671,891 |
| 2020 | Pasithea Therapeutics Corp. (KTTA) | Chief Executive Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.